Your samples don't need a passport.
The first bioequivalence research centre in the Middle East. Bioequivalence studies, LC-MS/MS bioanalysis, formulation and drug registration, done here in the UAE by First Gulf Pharmaceuticals Centre. One team, from the first sample to the final report.
From the molecule to the market:
Where to start
Pick the one that sounds like you
You have a generic to register
Start with a feasibility review: we check the reference product, the bioequivalence design and the registration route.
Plan my studyYou have samples to analyse
Send us the analyte, the matrix and the number of samples. We confirm the method and quote in writing.
Request an analysisYou have a product to bring in
We review your dossier, register the product and can distribute it to hospitals and pharmacies.
Register my productWhat we do
Research, laboratory and regulatory work under one roof
Bioequivalence and Clinical Research (CRO)
A generic medicine cannot be registered until it is shown to behave in the body like the reference product.
DetailsBioanalytical and Drug Analysis Laboratory
Sending samples abroad for analysis adds weeks, cost and risk to the sample itself.
DetailsDrug Formulation Development
A formulation that fails dissolution or stability late in development costs months and a full batch.
DetailsDrug Registration and Regulatory Affairs
Registration files get rejected or delayed for gaps that could have been caught before submission.
DetailsMedical Supplies Distribution
Hospitals and pharmacies need reliable supply of the right products, with the paperwork in order.
DetailsHospital and Medical Facility Development
New laboratories, pharmacies and medical facilities lose months to design changes and licensing gaps.
DetailsWhat you receive
Every result comes back in writing
Each batch of samples ends with a signed certificate of analysis: the method, the specification, the result and a clear verdict. Clinical studies end with a full study report written for your registration dossier.
| Test | Specification | Result | |
|---|---|---|---|
| Assay (LC-MS/MS) | 95.0 – 105.0 % | 99.4 % | Complies |
| Related substances, total | ≤ 1.0 % | 0.32 % | Complies |
| Dissolution, 30 min | ≥ 80 % (Q) | 92 % | Complies |
| Water content | ≤ 2.0 % | 0.8 % | Complies |
This is the format of the certificate you receive. The product, batch and figures are illustrative.
Beyond medicines
If it can be measured, we can help you measure it
Our methods cover biological, food, plant and environmental samples. A few examples of the work our laboratory is set up for:
Quantifying nutrients, residues and bioactive compounds in camel milk and its products.
Extract characterisation and compound profiling from date palm seeds.
Measuring plant growth regulators at trace levels in plant tissue.
Trace-level detection of antibiotic residues in wastewater and treated water.
Quantifying neurotransmitters in tissue samples for university research.
Drug and metabolite concentrations in plasma for pharmacokinetic and bioequivalence studies.
How a project runs
Five steps, agreed in writing before we start
Tell us about the product or samples. We sign a non-disclosure agreement first if you need one.
We confirm the study design or the analytical method, the timeline and the price, in writing.
For clinical studies, ethics and regulatory approvals are in place before any volunteer is dosed.
Samples are logged, analysed with calibration standards and quality controls, and reviewed by a second analyst.
You receive a signed certificate of analysis or a final study report, ready for your dossier or publication.
Our values
What you can hold us to
Every method validated, every sample logged, every result reviewed by a second analyst.
Every study and every analysis exists to bring safe, effective treatment to patients.
Studies and dossiers written for the regulator who will read them.
A non-disclosure agreement before any confidential file, formulation or sample.
A signed certificate of analysis or study report for every project.
One point of contact from the first enquiry to the final report.
Founder & CEO message
Dr. Mariam Al MansooriFounder & CEO · First Gulf Pharmaceuticals CentreWe believe that every scientific discovery is a step toward better treatment and a healthier life.
Where we are
Dubai today, Al Ain next
Floor 15, Office B, Jumeirah Emirates Towers, Dubai, United Arab Emirates. Tel +971 4 351 5959.
Our new research and laboratory centre in Al Ain, close to the universities and research community of the region.
FAQ
Questions we are often asked
What does FGPC do?
First Gulf Pharmaceuticals Centre is the first bioequivalence research centre in the Middle East, operating in the UAE since 2012. We run bioequivalence studies, analyse samples by LC-MS/MS, develop formulations, register medicines, and distribute medical supplies.
Do I need to send my samples abroad?
No. Our aim is that your samples are analysed here in the UAE, which saves shipping time and protects sample integrity.
Can you analyse samples that are not medicines?
Yes. Our methods cover biological, food, plant and environmental samples, such as camel milk, plant tissue and wastewater.
How do you protect our data and formulations?
We sign a non-disclosure agreement before receiving any confidential information, and results are shared only with you.
How do you price a study or an analysis?
Every project is quoted in writing after we understand the product, the method and the number of samples. You approve the quotation before any work starts.
Who manages FGPC?
FGPC was founded in 2012 by Dr. Mariam Al Mansoori and is managed by Netus Health.
Tell us about your product or your samples
We reply with the right method, a timeline and a written quotation. A non-disclosure agreement comes first if you need one.